Clinical trial
Ferumoxytol-enhanced Magnetic Resonance Imaging for the Interpretation of Vascular Defects
NCT02954510 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ferumoxytol-enhanced Magnetic Resonance Imaging for the Interpretation of Vascular Defects
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 1, 2017
- Completion date
- February 27, 2024
- Enrollment
- 185 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.